Home Business Tata Capital will invest Rs 255 Crores in Biocon Biologics

Tata Capital will invest Rs 255 Crores in Biocon Biologics

DELHI : Biotechnology major Biocon on Friday said Tata Capital Growth Fund will invest USD 30 million ( ₹225 crore) in its subsidiary Biocon Biologics to accumulate 0.85 per cent equity stake within the company.

The firm said this deal values Biocon Biologics at USD 3.5 billion.

In a regulatory filing, Biocon said the board of its subsidiary Biocon Biologics India has approved a primary equity investment by Tata Capital Growth Fund.

As per the terms of the proposed agreement, Tata Capital will invest USD 30 million ( ₹225 crore) for a 0.85 per cent minority stake within the biosimilar business.

Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics, the biotechnology major added.

The transaction is subject to plain condition precedents and approvals.

Dr Christiane Hamacher, CEO, Biocon Biologics, said this equity infusion is that the next step within the company’s journey of unlocking value.

“Through prudent investments in research and development and high-quality manufacturing infrastructure we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio and achieving a target revenue of USD 1 billion in fiscal year 2021-22,” Hamacher added.

Akhil Awasthi, Managing Partner, Tata Growth PE, said this investment is in line with its specialise in export-oriented manufacturing in world beating companies.

Shares of Biocon were trading 0.53 per cent higher at ₹405.55 apiece on BSE

Latest

Riot Hit area of Bengaluru resemble war zone

Riot Hit area of Bengaluru resemble war zone Pulakeshinagar area in Bengaluru resembled a war zone hours after an...

Modi to launch new, transparent scheme to reward honest taxpayers

PM Modi will launch a news tax scheem tomorrow. 'Transparent Taxation' will be launched by PM Modi vai video-conferencing tomorrow.

How covid vaccines will be distributed in India?

After Russia claiming that it has developed the world's first covid vaccine offering "sustainable immunity" against covid-19. An committee headed by NITI...

Dell launches new 14-inch convertible laptop latitude 7410 chromebook Enterprise

Dell has launched the new Latitude 7410 Chromebook Enterprise, a 14-inch convertible business laptop. With the new laptop, Dell expands its Latitude...

Shift in Habits due to pandemic: gamers seeking upgrade in gaming experience

Delhi: PC and console gaming grows due to covid-19 induced shift in habits Several PC brands have reported up...